Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes"

Lung Cancer. 2019 Nov:137:159-160. doi: 10.1016/j.lungcan.2019.08.020. Epub 2019 Aug 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms*
  • Mutation
  • Proto-Oncogene Proteins p21(ras)

Substances

  • KRAS protein, human
  • ErbB Receptors
  • Proto-Oncogene Proteins p21(ras)